Keyphrases
United States
71%
Diabetes
61%
Pharmacokinetics
53%
Pharmacist
53%
Oxidative Stress
52%
Medicare Beneficiaries
50%
Keratoconus
45%
Glaucoma
42%
Haloperidol
40%
Confidence Interval
39%
Alzheimer's Disease
35%
Negative Allosteric Modulator
35%
Drug Interactions
34%
Type 1 Diabetes Mellitus (T1DM)
34%
Lung
33%
Healthcare Expenditure
32%
Older Adults
32%
Antidepressants
32%
Medicaid
31%
Type 2 Diabetes Mellitus (T2DM)
31%
Mycoplasma
29%
Comorbidity
29%
AIDS/HIV
29%
Meta-analysis
28%
Schizophrenic Patients
27%
Nanoparticles
26%
HIV Patients
26%
Mouse Model
25%
Metabotropic Glutamate Receptor 5 (mGluR5)
25%
Metabolism
24%
Depression Treatment
24%
Pharmacy Students
24%
Medicare
22%
Systematic Meta-analysis
22%
Clozapine
22%
Mycoplasma Pulmonis
22%
West Virginia
22%
Plasma Concentration
21%
Risk Factors
21%
Odds Ratio
21%
Histone Deacetylase Inhibitor (HDACi)
21%
Pharmacy
20%
Diabetic
20%
Adjusted Odds Ratio
20%
Chronic Conditions
20%
Hypertension
20%
Parkinson's Disease
19%
Healthcare Utilization
19%
Retina
19%
Antipsychotics
18%
Retinal Ganglion Cells
18%
Medicaid Beneficiaries
17%
Cornea
17%
Healthcare Professionals
17%
Prescription Drugs
17%
Breast Cancer
17%
Small Molecules
17%
Thailandepsin A
16%
Ritonavir
16%
Health Care Costs
16%
Retrospective Cohort Study
16%
Osteoarthritis
16%
Hospitalization
15%
Neurodegenerative Diseases
15%
Human Corneal Fibroblasts
15%
Student Pharmacists
15%
Oxidative Damage
15%
Mental Illness
15%
Adverse Effects
15%
Veterans Health Administration
15%
Pharmacodynamics
15%
Hypoxia
15%
Optic Nerve
15%
Healthy Volunteers
15%
FK228
14%
Extracellular Matrix
14%
Non-Hispanic White
14%
Statins
14%
Staphylococcus Aureus
14%
Pharmacotherapy
14%
Tolerability
14%
Health-related Quality of Life
14%
Respiratory Disease
14%
Ethanol
13%
Warfarin
13%
Population Pharmacokinetics
13%
Antiretroviral Therapy
13%
Body Mass Index
13%
Vancomycin
13%
Medication Adherence
12%
Global Burden of Disease 2019
12%
Alzheimer's Dementia
12%
Chronic Obstructive Pulmonary Disease
12%
Immunization
12%
Structure-activity Relationship
12%
Diabetes Management
12%
5-hydroxytryptamine3 Receptor
12%
Polypharmacy
12%
Lopinavir
12%
Medical Expenditure Panel Survey
12%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Disease
67%
HIV
62%
Receptor
45%
Malignant Neoplasm
42%
Nanoparticle
39%
Allosteric Modulator
36%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
36%
Infection
35%
Antidepressant
32%
Prevalence
30%
Diabetes Mellitus
28%
Prescription Drug
27%
Keratoconus
26%
Reduced Haloperidol
26%
Drug Interaction
24%
Pharmacotherapy
24%
Adverse Event
23%
Normal Human
23%
Opiate
23%
Alzheimer's Disease
23%
Pharmacodynamics
22%
Structure Activity Relationship
20%
Typical Antipsychotic
20%
Clozapine
20%
Ritonavir
19%
Neoplasm
18%
Histone Deacetylase Inhibitor
17%
Staphylococcus Aureus
17%
Antioxidant
16%
Antipsychotic
16%
Cohort Study
16%
Cross-Sectional Study
16%
Metabotropic Receptor
16%
Chronic Obstructive Lung Disease
15%
Clinical Trial
15%
Comorbidity
15%
Antiinfective Agent
14%
Side Effect
14%
Tolerability
14%
Glaucoma
14%
Therapeutic Drug Monitoring
14%
Non Insulin Dependent Diabetes Mellitus
14%
Injury
14%
Parkinson's Disease
14%
Statin (Protein)
13%
Carbon 14
13%
Penicillinase
13%
Drug-Drug Interaction
13%
Drug Development
12%
Reactive Oxygen Metabolite
12%
Mouse Model
12%
Human Immunodeficiency Virus Infection
12%
Proteinase Inhibitor
12%
Infectious Agent
11%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
11%
Leporidae
11%
Vancomycin
11%
Breast Cancer
11%
Arachidonic Acid
11%
Positive Allosteric Modulator
11%
Chemotherapy
11%
Nitric Oxide
10%
Chronic Pain
10%
Serotonin 3A Receptor
10%
Fibrosis
10%
Adenosine Triphosphate
10%
Antibiotics
10%
Prostate Cancer
10%
Warfarin
10%
Selective Serotonin Reuptake Inhibitor
10%
Antibacterial Activity
10%
Cigarette Smoke
9%
Hydrogen Peroxide
9%
Doxorubicin
9%
Clostridium Difficile Infection
9%
Pharmacogenetics
9%
Polypharmacy
9%
IC50
9%
Sex Hormone
9%
Wound Healing
9%
Lopinavir Plus Ritonavir
9%
Major Depression
9%
Cytochrome P450
8%
Bioavailability
8%
Tenofovir
8%
CYP3A4
8%
Sphingolipid
8%
Olanzapine
8%
Gene Delivery
8%
Placebo
8%
Protein Kinase C
8%
Tablet
8%
Antidiabetic Agent
8%
Multiple Chronic Conditions
8%
Cytotoxicity
8%
Combination Therapy
8%
Glutamate Receptor
8%
Community Pharmacy
8%
Escherichia coli
8%